Literature DB >> 7567249

Spontaneous colonic ischemia in a patient with Riley-Day syndrome.

K E Applegate1, S K Sargent.   

Abstract

Familial dysautonomia, or Riley-Day syndrome, is a hereditary disturbance in the autonomic and peripheral sensory nervous systems, first described by Riley, Day, and colleagues in 1949 [1, 2]. Previous reports of myocardial infarction and avascular necrosis in bone suggest that these patients are at risk for ischemia at certain organ sites [3, 4]. We report a case of spontaneous colonic ischemia and stricture which resulted in colocutaneous fistula formation and eventual colonic resection in a child with Riley-Day syndrome.

Entities:  

Mesh:

Year:  1995        PMID: 7567249     DOI: 10.1007/BF02011113

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  5 in total

1.  Roentgenographic findings in familial dysautonomia.

Authors:  R H KIRKPATRICK; C M RILEY
Journal:  Radiology       Date:  1957-05       Impact factor: 11.105

2.  Central autonomic dysfunction with defective lacrimation; report of five cases.

Authors:  C M RILEY; R L DAY
Journal:  Pediatrics       Date:  1949-04       Impact factor: 7.124

3.  Aseptic necrosis in familial dysautonomia.

Authors:  J S Mitnick; F B Axelrod; N B Genieser; M Becker
Journal:  Radiology       Date:  1982-01       Impact factor: 11.105

4.  Myocardial infarction association with the Riley-Day syndrome.

Authors:  R Reshef; D Aderka; H Suprun; G Manelis; J Manelis
Journal:  Am Heart J       Date:  1977-10       Impact factor: 4.749

5.  Fundoplication and gastrostomy in familial dysautonomia.

Authors:  F B Axelrod; T H Gouge; H B Ginsburg; B S Bangaru; C Hazzi
Journal:  J Pediatr       Date:  1991-03       Impact factor: 4.406

  5 in total
  1 in total

Review 1.  Current treatments in familial dysautonomia.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Cristina Fuente-Mora; Leila Percival; Carlos Mendoza-Santiesteban; Horacio Kaufmann
Journal:  Expert Opin Pharmacother       Date:  2014-10-17       Impact factor: 3.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.